Abstract:Background: Sophisticated modern radiation therapy treatments require comprehensive validation in 3D. Purpose: Investigation and characterization of a novel 3D dosimetry system consisting of ClearView radiochromic gel dosimeters (commercially available from Modus Inc) and an in-house telecentric optical CT scanner DLOS (the Duke Large Field of View Optical-CT Scanner). Methods: Spectrophotometry measurements were made on small volumes of ClearView gel irradiated with 6X photon doses up to 40 Gy to determine linearity and temporal stability of dose response. Clinical evaluation of Clearview/DLOS system was conducted in two phases. Phase one involved simple photon and electron benchmark irradiations, delivered to 15 and 10 cm diameter dosimeters, at various energies and doses. Phase 2 investigated application to the verification of two single isocenter multi-target (SIMT) stereotactic radiosurgery (SRS) deliveries. These were patient treatments for two and five brain lesions, respectively, and delivered to 15 cm diameter dosimeters. SIMT treatments were delivered by Varian TrueBeam 6X with doses of 40 Gy. For dose read-out, dosimeters were optically scanned in the DLOS both pre- and post- irradiation (within 24 h). 3D reconstructions (1 mm3 resolution) of the change in linear-optical- attenuation (proportional to dose) was obtained using in-house software and 3D Slicer. Measured and predicted (Eclipse TPS) doses were compared through percent depth-dose (PDD), cross plane and in-plane profiles, and relative 3D gamma analysis (performed at a range of 7%/4 mm down to 2%/2 mm). Regions of known artifacts were excluded from analysis (jar base, neck, and wall). The SIMT SRS deliveries were additionally compared to SciMoca, an independent Monte Carlo second check software. Results: Linearity of dose response was confirmed with R2 ≥ 0.9986 at both 520 and 630 nm wavelengths and at three post-irradiation time points: 21 h, 6 and 10 days. Dose profiles of all benchmark irradiations, in both 15 and 10 cm dosimeters, show good agreement in useable areas of the gel compared to Eclipse dose calculations, with root mean square errors (RMSE) ≤ 0.0054, and R2 ≥ 0.9808. Gamma pass rates for the 15 cm dosimeter benchmark irradiations were ≥ 94% at 2%/2 mm (central axis), ≥ 90% at 3%/3 mm (left lateral), ≥ 90% at 2%/2 mm (electron), and ≥ 94% at 3%/2 mm (stacking field). Similar high passing rates were observed for benchmark irradiations to the smaller 10 cm diameter dosimeters. Very high Gamma pass rates were found for SIMT SRS deliveries, with 99.82% and 97.80% at 3%/2 mm, for the two and five target plans, respectively. Conclusion: This work presents the first investigation of ClearView dosimeters in combination with a telecentric optical-CT scanner (DLOS). Simple benchmark irradiations demonstrate ClearView/DLOS can accurately recreate and measure relative 3D dose within non-artifact regions (i.e., > 1 cm away from walls). Application to SIMT SRS deliveries demonstrated the viability of the system as a means for comprehensive 3D verification of complex treatment deliveries as well as confirming the treatment planning system dose distribution. The results indicate that DLOS/ClearView system is a highly effective 3D verification tool for SIMT irradiations and can be applied with 3%/2 mm gamma criteria where passing rates of > 95% are to be expected.

An efficient protocol for commissioning radiophotoluminescence dosimeters for radiotherapy dosimetry audits

IAEA/WHO postal dosimetry audit methodology for electron beams using radio photoluminescent dosimeters

The IAEA remote audit of small field dosimetry for testing the implementation of the TRS‐483 code of practice

An external dosimetry audit programme to credential static and rotational IMRT delivery for clinical trials quality assurance

An international film dosimetry intercomparison to establish a multi‐center audit framework

Lifetime extension of optically stimulated luminescent dosimeters above 10 gy

Relative Sensitivities and Correlation of Factors Introducing Uncertainty in Radiotherapy Dosimetry Audits

Measuring dose in lung identifies peripheral tumour dose inaccuracy in SBRT audit

Challenges for the Implementation of Primary Standard Dosimetry in Proton Minibeam Radiation Therapy

Feasibility of determining external beam radiotherapy dose using LuSy dosimeter

Interlaboratory comparison of high-throughput protein biomarker assay quantifications for radiation exposure classification

Design and commissioning of a Silicon Photomultiplier-based dosimeter for Low Dose Rate (LDR) oncological brachytherapy

Investigation of a 3D dosimetry system utilizing radio-chromic gel and telecentric optical-CT readout

Clinical Validation of myOSLchip system for Radiotherapy Dosimetry

A single-institution experience with 177Lu RPT workflow improvements and qualifying the SPECT/CT imaging for dosimetry

Technical note: Visual, rapid, scintillation point dosimetry for in vivo MV photon beam radiotherapy treatments

Technical Note: A Novel Electromagnetic-Tracked Scintillation Dosimeter for Accurate In Vivo Dosimetry in HDR Brachytherapy

Time-resolved in vivo luminescence dosimetry for online error detection in pulsed dose-rate brachytherapy

Characterization of a fiber-coupled Al2O3:C luminescence dosimetry system for online in vivo dose verification during 192Ir brachytherapy

Alanine/EPR dosimetry for mailed intercomparison at ocular proton therapy facilities-preliminary results for three centres for irradaitions at CCB IFJ PAN eyeline

Accurate dosimetry: an essential step towards good clinical practice in nuclear medicine